# Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM)

> **NCT04686279** · PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 8 (actual)

## Conditions studied

- HIV/AIDS
- HIV Prevention

## Interventions

- **DRUG:** Tenofovir Douche

## Key facts

- **NCT ID:** NCT04686279
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2023-10-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04686279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04686279, "Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04686279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*